Spyros A Kalams MD
Professor, Medicine, Vanderbilt University School of Medicine
Join to View Full Profile
3601 21st Ave SNashville, TN 37232
Phone+1 615-322-3000
Fax+1 615-936-0605
Dr. Kalams is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Massachusetts General Hospital/Brigham and Women's HospitalFellowship, Infectious Disease, 1990 - 1994
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1987 - 1990
Uconn School Of MedicineClass of 1987
Certifications & Licensure
TN State Medical License 2002 - 2027
MA State Medical License 1989 - 2004
American Board of Internal Medicine Infectious Disease
Clinical Trials
- Immune Responses in HIV-Positive Patients Receiving an Anti-HIV Drug Combination When Given the HIV Vaccines Remune and vCP1452
- Safety of and Immune Response to a New HIV Vaccine: HIV CTL MEP Start of enrollment: 2004 Apr 01
- Study of an HIV Preventive Vaccine Given With or Without an Adjuvant in HIV Uninfected Adults
- Join now to see all
Publications & Presentations
PubMed
- CD3+ T-cell: CD14+ monocyte complexes are dynamic and increased with HIV and glucose intolerance.Laventa M Obare, Joshua Simmons, Jared Oakes, Xiuqi Zhang, Cindy Nochowicz
Journal of Immunology. 2025-02-28 - HIV-1 adapts to HLA class II-associated selection pressure exerted by CD4and CD8T cells.Eric Alves, Jennifer Currenti, Keeley Crawford, Abha Chopra, Ramesh Ram
Science Advances. 2025-02-14 - Immunogenicity and Reactogenicity of High- or Standard-Dose Influenza Vaccine in a Second Consecutive Influenza Season.Hannah Bahakel, Andrew J Spieker, Haya Hayek, Jennifer E Schuster, Lubna Hamdan
The Journal of Infectious Diseases. 2025-02-04
Press Mentions
Researchers Use Fight Against COVID to Help with Development of HIV VaccineMarch 1st, 2022- More Unvaccinated People Still Need First COVID Vaccine, TN Doctors SayOctober 12th, 2021
- Vanderbilt to Give Booster Shots to Moderna Trial ParticipantsSeptember 20th, 2021
- Join now to see all
Grant Support
- Vanderbilt HIV Clinical Trials Unit (CTU)VANDERBILT UNIVERSITY MEDICAL CENTER2007–2027
- Vanderbilt HIV Clinical Trials Unit (CTU)VANDERBILT UNIVERSITY MEDICAL CENTER2007–2027
- Vanderbilt Infection Pathogenesis and Epidemiology Research Training ProgramVANDERBILT UNIVERSITY MEDICAL CENTER1995–2026
- Vanderbilt Infection Pathogenesis and Epidemiology Research Training ProgramVANDERBILT UNIVERSITY MEDICAL CENTER1995–2026
- Single cell molecular analysis of influenza vaccine responses in elderly individualsVANDERBILT UNIVERSITY MEDICAL CENTER2019–2025
- Single cell molecular analysis of influenza vaccine responses in elderly individualsVANDERBILT UNIVERSITY MEDICAL CENTER2019–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
